New Delhi: The National Pharmaceutical Pricing Authority (NPPA) has fixed a ceiling price of Rs. 217.74 per ml for Insulin Glargine 100IU/ml Pens, which is set to increase to Rs. 244.13 with effect from 1.04.2023, due to a 12.1218% increase in the Wholesale Price Index (WPI) under the Drug Price Control Order of 2013. This […] More
Scientists have shown that low carbohydrate consumption is significantly associated with increased insulin resistance in healthy, lean people [1]. Benefits and risks Diet is a powerful mediator of health and longevity. While there is broad consensus on what dietary components are dangers to be avoided, such as highly processed foods, there is little consensus on […] More
Australia: Pre-pregnancy insulin, fasting blood glucose (FBG), and insulin resistance may be used as early markers for predicting the incidence of gestational diabetes mellitus (GDM), a recent study has shown. The study was featured online in The Journal of Maternal-Fetal & Neonatal Medicine on 31 Mar 2023. “The measurement of pre-pregnancy biomarkers might be more […] More
New Delhi: Based on the safety data of 30 Indian subjects in the global clinical trial of Insulin Icodec, the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) has granted approval to drug major Novo Nordisk for the continuation of the trial of the antidiabetic drug Insulin Icodec with already […] More
U.S. : Novo Nordisk said on Tuesday it would cut U.S. list prices for several insulin products by up to 75% next year, joining rival Eli Lilly and Co as political pressure mounts to make these life-sustaining diabetes treatments more affordable. The moves follow the passing of President Joe Biden’s Inflation Reduction Act last year that […] More
Here you'll find all collections you've created before.
